Cite
HARVARD Citation
Wong, P. et al. (2022). Milvexian, an orally bioavailable, small‐molecule, reversible, direct inhibitor of factor XIa: In vitro studies and in vivo evaluation in experimental thrombosis in rabbits. Journal of thrombosis and haemostasis. pp. 399-408. [Online].